Log In
BCIQ
Print this Print this
 

CANMab, Hertraz (Myl-1401O)

Also known as: biosimilar trastuzumab

  Manage Alerts
Collapse Summary General Information
Company Biocon Ltd.
DescriptionBiosimilar of trastuzumab, a humanized mAb against epidermal growth factor receptor 2 (HER2; EGFR2; ErbB2; neu)
Molecular Target Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)
Mechanism of ActionBinds HER2/neu; Antibody; Biosimilar
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today